[1]
“Rezafungin for Candidemia and Invasive Candidiasis: A Focus on the Pharmaceutical Development, Related Patents, and Prospects”, AJP, vol. 18, no. 04, Dec. 2024, doi: 10.22377/ajp.v18i04.5818.